HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC
- Status
- UNKNOWN
- Phase
- PHASE2
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
- Status
- WITHDRAWN
- Phase
- PHASE3
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- NA
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
NeuWave Microwave Ablation HCC China Study
- Status
- COMPLETED
- Phase
- NA
TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B
- Status
- UNKNOWN
- Phase
- PHASE3
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria
- Status
- WITHDRAWN
- Phase
- PHASE2
HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Yliver as a Test to Early Diagnose HCC
- Status
- COMPLETED
- Phase
- N/A